P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLCC. Zhou, Chengping Hu, G. Chen et al.|Journal of Thoracic Oncology|2021Cited by 7
UK real-world data of radium-223 dichloride in metastatic prostate cancerManreet Randhawa, G. M. RACE, Amarnath Challapalli et al.|Nuclear Medicine Communications|2025Cited by 1